Cargando…

Erratum: Viswanathan, A., et al. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624

Detalles Bibliográficos
Autores principales: Viswanathan, Anisha, Musa, Aliyu, Murugesan, Akshaya, Vale, João R., Afonso, Carlos A. M., Mani, Saravanan Konda, Yli-Harja, Olli, Candeias, Nuno R., Kandhavelu, Meenakshisundaram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762400/
https://www.ncbi.nlm.nih.gov/pubmed/33297601
http://dx.doi.org/10.3390/cells9122631
_version_ 1783627796813185024
author Viswanathan, Anisha
Musa, Aliyu
Murugesan, Akshaya
Vale, João R.
Afonso, Carlos A. M.
Mani, Saravanan Konda
Yli-Harja, Olli
Candeias, Nuno R.
Kandhavelu, Meenakshisundaram
author_facet Viswanathan, Anisha
Musa, Aliyu
Murugesan, Akshaya
Vale, João R.
Afonso, Carlos A. M.
Mani, Saravanan Konda
Yli-Harja, Olli
Candeias, Nuno R.
Kandhavelu, Meenakshisundaram
author_sort Viswanathan, Anisha
collection PubMed
description
format Online
Article
Text
id pubmed-7762400
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77624002020-12-26 Erratum: Viswanathan, A., et al. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624 Viswanathan, Anisha Musa, Aliyu Murugesan, Akshaya Vale, João R. Afonso, Carlos A. M. Mani, Saravanan Konda Yli-Harja, Olli Candeias, Nuno R. Kandhavelu, Meenakshisundaram Cells Erratum MDPI 2020-12-07 /pmc/articles/PMC7762400/ /pubmed/33297601 http://dx.doi.org/10.3390/cells9122631 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Erratum
Viswanathan, Anisha
Musa, Aliyu
Murugesan, Akshaya
Vale, João R.
Afonso, Carlos A. M.
Mani, Saravanan Konda
Yli-Harja, Olli
Candeias, Nuno R.
Kandhavelu, Meenakshisundaram
Erratum: Viswanathan, A., et al. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624
title Erratum: Viswanathan, A., et al. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624
title_full Erratum: Viswanathan, A., et al. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624
title_fullStr Erratum: Viswanathan, A., et al. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624
title_full_unstemmed Erratum: Viswanathan, A., et al. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624
title_short Erratum: Viswanathan, A., et al. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624
title_sort erratum: viswanathan, a., et al. battling glioblastoma: a novel tyrosine kinase inhibitor with multi-dimensional anti-tumor effect (running title: cancer cells death signalling activation). cells 2019, 8, 1624
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762400/
https://www.ncbi.nlm.nih.gov/pubmed/33297601
http://dx.doi.org/10.3390/cells9122631
work_keys_str_mv AT viswanathananisha erratumviswanathanaetalbattlingglioblastomaanoveltyrosinekinaseinhibitorwithmultidimensionalantitumoreffectrunningtitlecancercellsdeathsignallingactivationcells201981624
AT musaaliyu erratumviswanathanaetalbattlingglioblastomaanoveltyrosinekinaseinhibitorwithmultidimensionalantitumoreffectrunningtitlecancercellsdeathsignallingactivationcells201981624
AT murugesanakshaya erratumviswanathanaetalbattlingglioblastomaanoveltyrosinekinaseinhibitorwithmultidimensionalantitumoreffectrunningtitlecancercellsdeathsignallingactivationcells201981624
AT valejoaor erratumviswanathanaetalbattlingglioblastomaanoveltyrosinekinaseinhibitorwithmultidimensionalantitumoreffectrunningtitlecancercellsdeathsignallingactivationcells201981624
AT afonsocarlosam erratumviswanathanaetalbattlingglioblastomaanoveltyrosinekinaseinhibitorwithmultidimensionalantitumoreffectrunningtitlecancercellsdeathsignallingactivationcells201981624
AT manisaravanankonda erratumviswanathanaetalbattlingglioblastomaanoveltyrosinekinaseinhibitorwithmultidimensionalantitumoreffectrunningtitlecancercellsdeathsignallingactivationcells201981624
AT yliharjaolli erratumviswanathanaetalbattlingglioblastomaanoveltyrosinekinaseinhibitorwithmultidimensionalantitumoreffectrunningtitlecancercellsdeathsignallingactivationcells201981624
AT candeiasnunor erratumviswanathanaetalbattlingglioblastomaanoveltyrosinekinaseinhibitorwithmultidimensionalantitumoreffectrunningtitlecancercellsdeathsignallingactivationcells201981624
AT kandhavelumeenakshisundaram erratumviswanathanaetalbattlingglioblastomaanoveltyrosinekinaseinhibitorwithmultidimensionalantitumoreffectrunningtitlecancercellsdeathsignallingactivationcells201981624